Accretion Nutraveda Limited (BSE: 544694)
Health Care · Pharmaceuticals · IN
Rs290.00
-4.92% today · +51.7% 1Y
Accretion Nutraveda Limited (BSE: 544694) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $21.69M.
Over the last twelve months the share price has gained 51.7%, trading between 150.10 and 313.00.
Tweenvest scores Accretion Nutraveda Limited across four factors: quality 66/100, value 44/100. Its strongest factor is quality.
544694 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.69M
- Revenue (TTM)
- $3.58M
- P/E
- 31.02
- EPS
- 9.35
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs313.00
- 52-week low
- Rs150.10
- Avg volume (3M)
- —
- Shares outstanding
- 7.24M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sat Kartar Life LimitedNSEI: SATKARTAR | $22.22M | Rs136.60 | -25.80% |
| Neurothera Labs Inc.TSXV: NTLX | $22.17M | CA$2.30 | -47.73% |
| Aytu BioPharma, Inc.NasdaqCM: AYTU | $22.01M | $2.02 | -0.25% |
| Accretion Pharmaceuticals LimitedNSEI: ACCPL | $21.70M | Rs188.95 | -7.06% |
| Public Joint-Stock Company "Pharmsynthez"MISX: LIFE | $21.52M | RUB— | — |
| Rubicon Organics Inc.TSXV: ROMJ | $21.31M | CA$0.45 | +2.27% |
| Philadelphia Pharmaceuticals CompanyASE: PHIL | $21.16M | JD2.00 | +5.26% |
| Coral Laboratories LimitedBSE: 524506 | $21.12M | Rs572.25 | +4.31% |
Figures last refreshed Oct 11, 2026.